Prognostic roles of endostatin, matrix metalloproteinase-2 and 9 and tissue inhibitors of metalloproteinase-1 in advanced non-small cell lung cancer
Egyptian Journal of Hospital Medicine [The]. 2016; 63 (April): 206-209
en Inglés
| IMEMR
| ID: emr-176202
ABSTRACT
Background and aim of the work Previous studies verified that Endostatin, matrix metalloproteinase [MMP] -2 and -9, in addition to tissue inhibitors of metalloproteinase [TIMP] -1 may play a crucial role in prognosis of non-small cell lung cancer [NSCLC]. In this study we will investigate the changes in the pretreatment serum levels of these factors and to evaluate their clinical implication in patients with advanced non-small cell lung cancer [NSCLC]
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Asunto principal:
Inhibidor Tisular de Metaloproteinasa-1
/
Metaloproteinasa 2 de la Matriz
/
Metaloproteinasa 9 de la Matriz
/
Endostatinas
/
Neoplasias Pulmonares
Límite:
Humanos
Idioma:
Inglés
Revista:
Egypt. J. Hosp. Med.
Año:
2016
Similares
MEDLINE
...
LILACS
LIS